Myomancy ADHD, Dyslexia and Autism

Shire FY sales up 36 pct, net loss 1.45 bln usd vs 278 mln profit … - Forbes


Shire FY sales up 36 pct, net loss 1.45 bln usd vs 278 mln profit …
Forbes, NY - Feb 21, 2008
Full-year diluted unadjusted loss per share was 268.7 cents, and sales of ADHD treatment Vyvanse were at the top end of consensus at 76 mln usd. …

Find Out More:

Books:

February 26th, 2008
Vyvanse

Leave a Reply

*Required

ADHD Boarding Schools

Pharmaceuticals GMP Procedures

Moving

Child Development

Natural ADHD Treatments



Discuss the topics raised by this article on the Myomancy Forum.

Archives


7427 posts since May 2004

Google Search

Search Myomancy for news and information about ADHD, Dyslexia and Autism including diagnosis techniques, treatments and the science behind them.

Myomancy Treatment Database

A comprehensive list of every type of treatment available for ADHD, Autism and Dyslexia reviewed and rated by people who have tried them is available on the Myomancy Treatment Database. It covers mainstream treatments focusing on Reading as well as those less recognised using Biofeedback, Dietry and Rhythm. There are also treatments that deal with specific issues such as Audiotory, Visual, Balance, Coordination, Memory. Some treatments are provided as special centers whilst others are available via Books, CDs, DVDs or Software.

Read the latest on ADHD, Dyslexia and Autism from Myomancy via RSS 2.0 or use FeedBurner: